Linked Life Data

6662194

Source:http://linkedlifedata.com/resource/pubmed/id/6662194

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
1984-3-2
pubmed:abstractText
A priming dose (15 mg/kg i.p.) of (+)-amphetamine sulfate combined with a 16 h subcutaneous infusion of 1.36 mg of the drug per hour to rats via its release from osmotic minipumps produced marked decreases in striatal dopamine (DA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and the synaptosomal uptake of [3H]DA which lasted for at least 12 weeks. The decrease in striatal DA persisted through 24 weeks after drug treatment. In contrast, striatal levels of DOPAC, HVA and synaptosomal DA uptake recovered to control levels by 24 weeks after amphetamine treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0014-2999
pubmed:author
pubmed:issnType
Print
pubmed:day
9
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
159-63
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Long-term effects of a priming dose and short-term infusion of amphetamine on striatal dopamine neurons in rats.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't